Advertisement
News
Subscribe to MDT Magazine News

Data from St. Jude Medical RESPECT Trial for PFO Closure Highlighted at International Stroke Conference 2013

February 8, 2013 8:00 am | by The Associated Press | Comments

ST. PAUL, Minn.--(BUSINESS WIRE)--Feb 8, 2013--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the presentation of additional data from its landmark RESPECT trial at the American Stroke Association’s International Stroke Conference 2013 in Honolulu. The RESPECT...

TOPICS:

IBM Watson Hard At Work: New Breakthroughs Transform Quality Care for Patients

February 8, 2013 12:30 am | by IBM | Comments

IBM, WellPoint, Inc. and Memorial Sloan-Kettering Cancer Center today unveiled the first commercially developed Watson-based cognitive computing breakthroughs. These innovations stand alone to help transform the quality and speed of care delivered to patients through individualized, evidence based medicine.

TOPICS:

Two-Year Clinical Study Supports Safety and Efficacy of Covidien Revascularization Device

February 7, 2013 6:42 pm | by The Associated Press | Comments

MANSFIELD, Mass.--(BUSINESS WIRE)--Feb 7, 2013--Covidien (NYSE:COV), a leading global provider of healthcare products, today released the results of the Solitaire™ FR Thrombectomy for Acute Revascularization (STAR) study. The two-year study evaluated the safety and efficacy of the Solitaire FR...

TOPICS:
Advertisement

Two-Year Clinical Study Supports Safety and Efficacy of Covidien Solitaire™ FR Revascularization Device

February 7, 2013 6:42 pm | by The Associated Press | Comments

MANSFIELD, Mass.--(BUSINESS WIRE)--Feb 7, 2013--Covidien (NYSE:COV), a leading global provider of healthcare products, today released the results of the Solitaire™ FR Thrombectomy for Acute Revascularization (STAR) study. The two-year study evaluated the safety and efficacy of the Solitaire FR...

TOPICS:

Senate Follows House in Launching Medical Device Tax Repeal Bill

February 7, 2013 6:01 pm | by Mass Device | Comments

Lawmakers deliver a 1-2-punch in launching parallel medical device tax repeal bills in the House of Representatives and then the Senate just a day apart. A bipartisan group of Senators today released a bill that would repeal the 2.3% medical device tax, closely following a parallel bill released in the House of Representatives yesterday.

TOPICS:

Judge Stays C.R. Bard Suit Against Hologic over Mammosite Device

February 7, 2013 4:50 pm | by Mass Device | Comments

A federal judge stays a patent infringement lawsuit filed by C.R. Bard subsidiary SenoRx over Hologic's Mammosite device for treating breast cancer. A federal judge in Delaware put a patent infringement spat between C.R. Bard subsidiary SenoRx and Hologic (NSDQ:HOLX) on hold for 90 days last week.

TOPICS:

American Association for Cancer Research to Host Congressional Briefing About Progress in Cancer Research

February 7, 2013 4:50 pm | by AACR | Comments

Deputy Director of the National Cancer Institute, Dr. Douglas Lowy, will address the audience. Event will showcase the AACR Cancer Progress Report, which is a call to action to make funding for the National Institutes of Health a national priority. A foremost expert in blood cancers will describe progress in multiple myeloma.

TOPICS:

CareFusion Reports First Half Fiscal 2013 Results

February 7, 2013 4:03 pm | by The Associated Press | Comments

CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported results for the three and six months ended Dec. 31, 2012. "Our consolidated first and second quarter financial results were led by strong performance across the Procedural Solutions segment, where each...

TOPICS:
Advertisement

Diabetes: Insulet and Dexcom Call It Quits on Development Agreement

February 7, 2013 3:34 pm | by Mass Device | Comments

Insulet and Dexcom decide not to pursue a joint development agreement to integrate Dexcom's continuous glucose monitoring technology with Insulet's insulin-infusing OmniPod. Diabetes technology makers Insulet and Dexcom Inc. abandoned a 5-year-old joint development deal that would have merged Dexcom's continuous glucose monitoring technology with Insulet's OmniPod insulin delivery system.

TOPICS:

Stung by Widening Losses, Accuray Plans $75M Debt Offering

February 7, 2013 2:53 pm | by Mass Device | Comments

On the heels of gaping losses and a more than 25% sales decline, Accuray announces plans for a $75 million debt round. Accuray (NSDQ:ARAY) plans to issue $75 million worth of convertible senior notes as it gears up to restructure its business after a year of widening losses. The Sunnyvale, Calif.-based medical device company said it will use the proceeds from the offering of debt due Feb. 1, 2018, to shore up its balance sheet.

Researchers Find a Genetic Marker for Aortic Valve Disease

February 7, 2013 2:13 pm | by Mass Device | Comments

A research consortium tracks down a genetic variant that doubles the risk of buildup in the aortic valve that can cause heart failure, stroke and sudden cardiac death. A team of researchers have pinpointed a gene that may be responsible for double a patient's risk of calcium buildup in the aortic valve, a condition linked with heart failure, stroke and sudden cardiac death. The finding may lead to new research and therapies, which are very limited for patients with narrowing, or stenosis, of the aortic valve.

TOPICS:

Losses Soar, Shares Plummet for Accuray

February 7, 2013 2:09 pm | by Mass Device | Comments

Accuray's fiscal 2nd quarter sales plunge and its losses gape wider, sending share prices down almost 10% today. Accuray (NSDQ:ARAY) shares lost nearly 10% today after the medical device company reported soaring losses and a nearly 27% sales slide for its fiscal 2nd quarter. The Sunnyvale, Calif.-based company, which makes radiation oncology equipment, posted losses of $29.2 million, or 40¢ per share, on sales of $77.8 million for the 3 months ended Dec. 31, 2012.

TOPICS:

Fully Automatic AED Plus from ZOLL Granted 510(k) Clearance by U.S. Food and Drug Administration

February 7, 2013 1:22 pm | by The Associated Press | Comments

CHELMSFORD, Mass.--(BUSINESS WIRE)--Feb 7, 2013--ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market and begin U.S. distribution of the new fully...

TOPICS:

CT Scanner Delivers Less Radiation

February 7, 2013 12:33 pm | by Massachusetts Institute of Technology | Comments

Faster, more sensitive scans and better image processing may reduce the risk of x-ray-related cancers. A new CT scanner exposes patients to less radiation while providing doctors with clearer images to help with diagnoses, according to researchers at the National Institutes of Health.

TOPICS:

Sorin Group Announces Preliminary Results for 2012

February 7, 2013 12:06 pm | by The Associated Press | Comments

MILAN--(BUSINESS WIRE)--Feb 7, 2013--At a meeting held today and chaired by Rosario Bifulco, the Sorin S.p.A. (MIL:SRN) Board of Directors analyzed the results for the fourth quarter 2012 and the preliminary unaudited consolidated results for the year of 2012. The final draft of the financial...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading